Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT02187705
NCT02187705CompletedNot Applicable

Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in Hospitals

Boehringer Ingelheim0 sites1,688 target enrollmentStarted: May 1999Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
1,688
Primary Endpoint
Number of patients with adverse events
Study OverviewStudy DesignEligibility CriteriaArms & InterventionsOutcomesInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The aim of this observational study was to supplement the data on efficacy, safety, and tolerability of telmisartan under daily conditions in hospitals

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients with essential hypertension
  • •Minimum age of 18 years

Exclusion Criteria

  • •Not applicable

Arms & Interventions

Patients with normotension at baseline

Intervention: Telmisartan tablets (Drug)

Patients with essential hypertension at baseline

Intervention: Telmisartan tablets (Drug)

Patients with isolated hypertension at baseline

Intervention: Telmisartan tablets (Drug)

Outcomes

Primary Outcomes

Number of patients with adverse events

Time Frame: Up to 14 days

Changes from baseline in blood pressure

Time Frame: Up to 14 days

Evaluation was performed separately for three patient groups depending on their hypertension status at baseline (normotension, essential hypertension and isolated hypertension)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Similar Trials

Completed
Not Applicable
Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in HospitalsHypertension
NCT02238262Boehringer Ingelheim2,318
Completed
Not Applicable
Micardis®. Observational Study in Patients With Essential HypertensionHypertension
NCT02200094Boehringer Ingelheim4,532
Completed
Not Applicable
Safety, Tolerability and Efficacy of Micardis® in Patients With Essential HypertensionHypertension
NCT02176850Boehringer Ingelheim19,870
Completed
Not Applicable
Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With HypertensionHypertension
NCT02242838Boehringer Ingelheim6,336
Completed
Not Applicable
Nice Morning- Safety and Efficacy Observational Study of Telmisartan in Hypertensive Patients in MulticentersHypertension
NCT00615108Boehringer Ingelheim3,148